Notes
SCAR = severe cutaneous adverse reactions
Reference
Health Canada. Summary Safety Review - Halaven (eribulin mesylate) - Assessing the potential Risk of severe skin side effects. Internet Document : 12 Mar 2018. Available from: URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/safety-reviews/halaven-assessing-potential-risk-severe-skin-side-effects.html
Rights and permissions
About this article
Cite this article
Insufficient data to prove eribulin directly linked to SCAR. Reactions Weekly 1694, 3 (2018). https://doi.org/10.1007/s40278-018-43405-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-43405-z